FDA and HHS should im­prove in­sti­tu­tion­al re­view board in­spec­tion prac­tices, GAO says

The US Gov­ern­ment Ac­count­abil­i­ty Of­fice has made four rec­om­men­da­tions to the FDA and HHS to im­prove their over­sight of in­sti­tu­tion­al re­view boards’ (IRBs) own in­spec­tions …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.